Michel Kaczorek
Nessuna posizione attualmente
Storia della carriera di Michel Kaczorek
Precedenti posizioni note di Michel Kaczorek
Società | Posizione | Inizio | Fine |
---|---|---|---|
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | Direttore/Membro del Consiglio | 20/11/2009 | 11/03/2014 |
Kephalios SAS
Kephalios SAS Medical SpecialtiesHealth Technology Kephalios SAS develops and designs medical equipment including mitral ring for minimally invasive and reversible correction of residual mitral regurgitation. The company was founded in April 2011 and is headquartered in Paris, France. | Presidente | - | - |
Statistiche
Distribuzione geografica
Francia | 3 |
Posizioni
Director/Board Member | 1 |
Chairman | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Neurokin SA
Neurokin SA BiotechnologyHealth Technology Neurokin is a venture-back bio-tech company based in Marseilles, France. Neurokin is specializing in the development of different pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. Neurokin's major objective is to identify new CDK inhibitors as neuroprotectants. Neurokin focuses on stroke, epilepsy, cerebral hypoxia after cardiac arrest and traumatic brain injury. As of May 2009, Neurokin has identified new neuroprotective drug candidates and has brought them to the regulatory preclinical stage. | Health Technology |
Kephalios SAS
Kephalios SAS Medical SpecialtiesHealth Technology Kephalios SAS develops and designs medical equipment including mitral ring for minimally invasive and reversible correction of residual mitral regurgitation. The company was founded in April 2011 and is headquartered in Paris, France. | Health Technology |
- Borsa valori
- Insiders
- Michel Kaczorek
- Esperienza